Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_2899_Библиотеки_им_академика_М_И_Перельмана
.pdf
•
•
•
•
Chapter3
Aorticstenosisandmitralregurgitation
Guideline:EuropeanSocietyofCardiology(ESC)/EuropeanAssociationfor
Cardio-Thoracic Surgery (EACTS) (2017 ESC/EACTS Guidelines for the
management of valvular heart disease):
https://academic.oup.com/eurheartj/article/38/36/2739/4095039
OUPdisclaimer:OxfordUniversity Press makesno representation, express
or implied, that the drugdosagesarecorrectand thatthe recommendations
are an exclusive or mandatory course of care. All health professionals
readingthistexthavearesponsibilitytoevaluateitsappropriatenessandtake
theindividualneedsofthepatientintoaccount.
Localtrustguidelines:pleaserefertoyourlocalguidelinesasnecessary.
Overview
Aorticstenosis (AS) and mitral regurgitation (MR) are the two most common valvular
pathologies in high-income countries. Patients often remain asymptomatic for an
extended period before cardiovascular decompensation which leads to the onset of
symptoms. In the asymptomatic phase, management involves optimization of
cardiovascularriskfactorsandregularsurveillance.Theonsetofsymptomsisassociated
withasignificantincreaseinadverseeventsandsuddencardiacdeath.Boxes3.1and3.2
describetheaetiologyofASandMR,respectively.
Box3.1Aetiologyofaorticstenosis
Calcificdegenerationoftheaorticvalve
Bicuspidaorticvalve
Rheumaticheartdisease
Congenital.
Box3.2Aetiologyofmitralregurgitation
https://t.me/med1917

•
•
•
•
•
•
•
•
•
•
•
•
Primary—abnormalityofmitralvalveapparatus:
Degenerative
Connectivetissuedisease
Rheumaticfever
Infectiveendocarditis
Papillarymusclerupture
Secondary—functional regurgitation due to distortion of the subvalvular apparatus with a
structurallynormalvalveandchordae:
Leftventriculardilatation(ischaemicandnon-ischaemic).
Diagnosis
History
Askabout:
Presenceofsymptomssuchasfatigue,exertionaldyspnoea,angina,syncope,lightheadedness,and
palpitations
Presenceofcardiovascularriskfactorsandcomorbidities
Functionalstatus
Historyofrheumaticfever.
Examination
Focusondetectingsignsandcomplications ofvalvularheartdisease(Table3.1andFig.
3.1).
https://t.me/med1917

Table3.1Possibleexaminationfindingsinpatientswithvalvularpathology
Aorticstenosis Mitralregurgitation
B Basalcrepitationsduetopulmonaryoedema
Hypoxia
Orthopnoea
C Heavingapexbeat
Slow-risingcentralpulse
Crescendo–decrescendomid-systolicmurmurradiatingtothecarotid
arteries
Softsecondheartsound
Displacedapexbeat
Pansystolicmurmurradiatingtothe
axilla
Thirdheartsound
Softfirstheartsound
AFiscommon
E Evidenceofinfectiveendocarditis(splinterhaemorrhages,Oslernodes,Janewaylesions)
Ankleoedema
Fig.3.1 Auscultation findings in aortic stenosis and mitral regurgitation. (a) There is a mid-systolic
crescendo–decrescendo ejection systolic murmur that radiates to the carotid arteries. There may be
reverse splitting or only a single audible second heart sound, due to delayed and softer aortic valve
closure(A2).Afourthheartsoundmaybepresentduetoforcefulatrialcontraction.(b)Thereisapansystolicmurmurthatradiatestotheaxilla.Thereisasoftfirstheartsound(S1)duetoincompletemitral
valve closure,andthereis splitting of the second heart sound due toearlyclosureof the aortic valve
(A2).Afourthheartsoundmaybepresentduetorapidventricularfilling.A2,aorticsecondheartsound;
ESM,ejectionsystolic murmur;PSM,pansystolic murmur;P2,pulmonarysecondheartsound;S1,first
heartsound;S3,thirdheartsound;S4,fourthheartsound.
https://t.me/med1917

•
•
•
•
•
•
Investigations
Bedside
ECG:lookforevidenceofleftventricular hypertrophy, leftatrialdilatation,left axisdeviation,
LBBB,AF,orQwavesduetoapreviousinfarct.
Bloods
SeeTable3.2.
Table3.2Bloods
U&E Kidneydiseaseisariskfactorforatheroscleroticdisease
Knowledgeofrenalfunctionisrequiredwhenprescribingdiuretics
FBC Anaemiamayexacerbatesymptoms
HbA1c Diabetesisariskfactorforatheroscleroticdisease
Lipidprofile Hyperlipidaemiaisariskfactorforatheroscleroticdisease
BNP ElevatedBNPisapredictorofpooreroutcomes
Imaging
ChestX-ray:lookforevidenceofheartfailureorvalvecalcification.InMR,cardiomegalymay
bepresentduetoleftventricularandatrialdilatation.
Other
Transthoracicechocardiography(TTE):confirmsdiagnosis,severity,andaetiology.
Transoesophageal echocardiography: sometimes used in MR or AS to further assess for
concomitantvalvepathology.
Exercise echocardiography: sometimes used when there is evidence of severe AS or MR on
echocardiographybutthepatientisasymptomatic. Thistestprovides prognosticinformationand
thepresenceofsymptomsmayjustifyearlysurgicalmanagement.
Cardiacmagneticresonanceimaging(MRI),cardiaccomputedtomography(CT),andcardiac
angiography:thesecanprovideadditionalinformationforsurgicalplanningandprognostication.
Diagnosticcriteria
SeeTable3.3.
https://t.me/med1917

•
•
•
•
1.
2.
3.
4.
Table3.3Criteriaforseverevalvulardisease
Aorticstenosis Mitralregurgitation
Clinical Presenceofsymptoms(angina,dyspnoea,syncope)
Qualitative Leftventricularhypertrophy
Valvemorphology
Quantitative Peaktrans-valvularpressuregradient>40mmHg
Peaktrans-valvularvelocity>4m/s
Valvearea<1cm
2
Effectiveregurgitantorificearea>40mm2
Regurgitantvolume>60mL/beat
Leftatrialorleftventricularenlargement
Source:datafrom2017ESC/EACTSGuidelinesforthemanagementofvalvularheartdisease.
Management
Patienteducation
Educatepatientsabouttheimportanceoffollow-upandreportingsymptomsassoonastheyoccur.
Lifestyleandsimpleinterventions
Supportpatientswithweightloss,smokingcessation,dietmodification,andexercise.
VigorousoranaerobicexerciseiscontraindicatedinsymptomaticASpatients.
Psychologicalinterventions
Palliativecareinputshouldbeconsideredforsymptomaticpatientsnoteligibleforinterventional
management.
Pharmacologicalmanagement
ThereisnoevidencethatmedicaltherapyimprovesthenaturalprogressionofASorMR.
Thefocusofmedicalmanagementis:
Totreatanymodifiablecardiovascularriskfactors(hypertension(seeChapter6),Type2diabetes
mellitus(seeChapter26),hyperlipidaemia)
Tomanageunderlying/concurrentheartfailure(seeChapter5)
To reduce preload in acute MR using nitrates and diuretics ± to use inotropes if there is
haemodynamicinstability
ToattempttomaintainsinusrhythminpatientswithAF(seeChapter4).
https://t.me/med1917

•
•
•
•
•
•
•
Surgicalmanagement
The strongestindication for intervention is the onsetof symptoms. Intervention can be
surgicalor percutaneous depending on the surgical risk of the patient. Decisions about
timingandmodeofinterventionneedtobemadebyamultidisciplinaryheartteamafter
consideringindividualrisksandbenefitsofintervention.
Mitralregurgitation
PrimaryMR:surgicalrepairisthepreferredmethodofintervention,withpercutaneousedge-toedgerepairreservedforpatientswithahighsurgicalrisk.Surgeryisindicatedinseveredisease,
whichisdeterminedbythe presenceofsymptoms, leftventricularejectionfraction (<60mmHg),
pulmonaryarterypressure(>50mmHg),andpresenceofAF
AcuteMR:ifthereishaemodynamicinstability,anintra-aorticballoonpumpmaybeusedprior
tointervention.
Aorticstenosis
Surgicalaorticvalvereplacement(SAVR): preferredmode ofinterventioninyounger patients
withseveresymptomaticASandlowsurgicalrisk
Transcatheter aortic valve implantation (TAVI): intervention of choice in patients aged >75
years
Balloonvalvuloplasty: canbe considered in haemodynamicallyunstable patientsasabridgeto
surgeryorTAVI.
Valvularpathologyandcoronaryheartdisease
InthepresenceofmoderateAS,ifCABGsurgeryisalsorequired,patientsshouldhaveanSAVR
Inthepresenceofmoderatesymptomatic MR,ifCABGsurgeryisalsorequired, patientsshould
haveamitralvalverepairatthesametime.
Complications
Left ventricular remodelling (hypertrophy and/or dilatation), pulmonary hypertension,
heart failure, AF (see Chapter 4), LBBB, and sudden cardiac death may occur as
complicationsoftheconditions.Infectiveendocarditismayoccurasacomplicationofan
intervention.
Monitoringandfollow-up
In asymptomatic patients with severe MR or AS, 6-monthly follow-up is advised with
careful screening for onset of symptoms and progression of echocardiographic
parameters.
https://t.me/med1917

Furtherreading
1.EuroSCOREIIsurgicalriskcalculator.Availableat:http://www.euroscore.org/calc.html
https://t.me/med1917

•
•
•
•
•
•
Chapter4
Atrialfibrillation
Guideline: NICE NG196 (Atrial fibrillation: diagnosis and management):
https://www.nice.org.uk/guidance/ng196
OUPdisclaimer:OxfordUniversity Press makesno representation, express
or implied, that the drugdosagesarecorrectand thatthe recommendations
are an exclusive or mandatory course of care. All health professionals
readingthistexthavearesponsibilitytoevaluateitsappropriatenessandtake
theindividualneedsofthepatientintoaccount.
Localtrustguidelines:pleaserefertoyourlocalguidelinesasnecessary.
Overview
Atrialfibrillation(AF)isacommonarrhythmiathatresultsindyssynchronouscontraction
oftheatriarelativetotheventricles.Patientswiththisconditionhaveanincreasedriskof
thromboembolismthatmayleadtostroke.
Diagnosis
History
About25–30%ofAFpatientsareasymptomatic(incidentalfinding).Othersmaypresent
with:
Shortnessofbreath
Palpitations
Chestdiscomfort
Syncopeorlight-headedness
Fatigue
Anembolicevent(stroke,transientischaemicattack(TIA);seeChapter56).
Aimtoidentifyanypossiblepredisposingcauses:
https://t.me/med1917

•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
Underlyinginfection
Heavyalcoholintake
Cocaineormarijuanause
Highcaffeineintake
Hypertension(seeChapter6)
Heartfailure
Structuralheartdisease:
Valvular(mitralstenosisorMR;seeChapter3)
Congenital(atrialseptaldefect)
Coronaryarterydisease
Hyperthyroidism(seeChapter19)
Pulmonary conditions, e.g. chronic obstructive pulmonary disease (COPD; see Chapter 81),
obstructivesleepapnoea.
Examination
Performafullcardiacexaminationincludingbloodpressure
Palpateforanirregularlyirregular±tachycardicpulse
Auscultateforirregularlyirregulartachycardia(ifinAFwithrapidventricularrate)±murmurs.
Investigations
Bedside
A12-leadECG(Fig.4.1andBox4.1).
Box4.1Diagnosingatrialfibrillation
AdiagnosisofAFrequiresECGevidenceofthefollowing:
IrregularRRintervals
AND
AbsenceofvisiblePwaves.
https://t.me/med1917

•
•
•
•
•
Fig.4.1Electrocardiogramrhythmstripdemonstratingatrialfibrillation.
ReproducedfromWijdicksEFMetal(2016)‘NeurocriticalCare2e’OxfordUniversityPress:Oxford,
withpermissionfromOxfordUniversityPress.
Bloods
Usebloodteststoscreenforpossibleunderlyingfactorswhichmightcauseorexacerbate
AF:
FBC(anaemia)
U&Eandboneprofile(electrolyteabnormalities,e.g.hyperkalaemia)
Thyroidscreen(hyperthyroidism)
Venousbloodgas(lactateforinfection)
Coagulationprofile(anticoagulationmayberequired)
Imaging
Transthoracicechocardiography
Mayrevealstructuralheartdiseaseand/orpresenceof thrombus.Itshouldbeofferedto
allpatientswithAF.
Other
AmbulatoryECGmonitoring
https://t.me/med1917
Соседние файлы в папке Библиотека им академика М.И. Перельмана
